IFI44L and systemic lupus erythematosus: Our previous studies were the first to find abnormal expression of IFI44L in SLE peripheral blood and overexpression of IFI44L was most significant in SLE rather than other autoimmune diseases, which provided a new idea for disclosing the pathogenesis of SLE [9].